CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 640 target
Drug / intervention
carboplatin +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00002623
NCT00002623Phase 3Completed

RANDOMIZED TRIAL OF SURGERY VERSUS RADIOTHERAPY IN PATIENTS WITH STAGE IIIa NON-SMALL CELL LUNG CANCER AFTER A RESPONSE TO INDUCTION-CHEMOTHERAPY

European Organisation for Research and Treatment of Cancer - EORTC·interventional·Posted Jan 27, 2003·Updated Jul 2, 2012

In Brief

A Phase 3 clinical trial evaluating carboplatin, cisplatin, and 2 other interventions for Lung Cancer. Completed, enrolled 640 participants across 30 sites in 5 countries.

Detailed Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving a chemotherapy drug before surgery may shrink the tumor so that it can be removed during surgery. Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known whether chemotherapy followed by surgery with or without radiation therapy is more effective than chemotherapy followed by radiation therapy alone in treating non-small cell lung cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy followed by surgery with or without radiation therapy to that of chemotherapy followed by radiation therapy alone in treating patients who have stage III non-small cell lung cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer
CountriesBelgium, France, Italy, Netherlands, United Kingdom
Collaborators--

Timeline

Phase 3CompletedFinished
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 27, 2003
Enrollment StartDec 1, 1994
Primary CompletionDec 1, 2002
TodayJul 2, 2026
Enrollment to primary: 8 yearsPosted 23.4 years ago

Interventions

carboplatindrug

cisplatindrug

conventional surgeryprocedure

radiation therapyradiation